TABLE 2.
Plasma carotenoid concentrations in the cystic fibrosis (CF) patients and the healthy control subjects1
CF patients | Control subjects | |||
---|---|---|---|---|
Lutein | Zeaxanthin | Lutein | Zeaxanthin | |
nmol/L | nmol/L | |||
1 | 85 | 34 | 182 | 81 |
2 | 67 | <10 | 134 | 66 |
3 | 69 | 35 | 256 | 83 |
4 | 105 | 38 | 110 | 60 |
5 | 69 | 33 | 202 | 77 |
6 | 83 | 33 | 223 | 77 |
7 | 183 | 55 | 127 | 55 |
8 | 64 | <10 | 136 | 43 |
9 | 66 | <10 | 347 | 131 |
10 | 76 | <10 | 182 | 81 |
x̄ ± SD | 87 ± 36.1 | 27 ± 15.8 | 190 ± 72.1 | 75 ± 23.6 |
Plasma lutein and zeaxanthin concentrations were measured on the same day as the macular pigment densities were measured and the visual performance tests were conducted. Laboratory reference ranges for healthy persons are 105–370 nmol/L for lutein and 34–117 nmol/L for zeaxanthin 37). There was an overall significant difference in plasma concentrations of lutein (unpaired t test, P < 0.001) and zeaxanthin (unpaired t test, P < 0.001) between the 2 groups.